Accustem Sciences (Accustem Sciences) Dividend Payout Ratio : 0.00 (As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Accustem Sciences Dividend Payout Ratio?

Accustem Sciences's dividend payout ratio for the months ended in Mar. 2024 was 0.00.

The historical rank and industry rank for Accustem Sciences's Dividend Payout Ratio or its related term are showing as below:

ACUT's Dividend Payout Ratio is not ranked ^*
in the Biotechnology industry.
Industry Median: 0.435
* Ranked among companies with meaningful Dividend Payout Ratio only.

As of today (2024-05-24), the Dividend Yield % of Accustem Sciences is 0.00%.

Accustem Sciences's Dividends per Share for the months ended in Mar. 2024 was $0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

Accustem Sciences Dividend Payout Ratio Historical Data

The historical data trend for Accustem Sciences's Dividend Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Accustem Sciences Dividend Payout Ratio Chart

Accustem Sciences Annual Data

Trend

Dec22

Dec23

Dividend Payout Ratio

Accustem Sciences Quarterly Data
	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Dividend Payout Ratio	Get a 7-Day Free Trial				-	-	-	-	-

Competitive Comparison of Accustem Sciences's Dividend Payout Ratio

For the Biotechnology subindustry, Accustem Sciences's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Accustem Sciences's Dividend Payout Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Accustem Sciences's Dividend Payout Ratio distribution charts can be found below:

* The bar in red indicates where Accustem Sciences's Dividend Payout Ratio falls into.

Accustem Sciences Dividend Payout Ratio Calculation

Dividend payout ratio measures the percentage of the company's earnings paid out as dividends.

Accustem Sciences's Dividend Payout Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Dividend Payout Ratio	=	Dividends per Share (A: Dec. 2023 )	/	EPS without NRI (A: Dec. 2023 )
	=	0	/	-0.18
	=	N/A

Accustem Sciences's Dividend Payout Ratio for the quarter that ended in Mar. 2024 is calculated as

Dividend Payout Ratio	=	Dividends per Share (Q: Mar. 2024 )	/	EPS without NRI (Q: Mar. 2024 )
	=	0	/	-0.05
	=	N/A

Accustem Sciences (OTCPK:ACUT) Dividend Payout Ratio Explanation

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

Accustem Sciences Dividend Payout Ratio Related Terms

Thank you for viewing the detailed overview of Accustem Sciences's Dividend Payout Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

Accustem Sciences (Accustem Sciences) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Accustem Sciences Inc (OTCPK:ACUT) » Definitions » Dividend Payout Ratio

Comparable Companies

Traded in Other Exchanges

N/A

Address

5 Penn Plaza, Suite 1954, Floor 19, New York, NY, USA, 10001

Website

http://www.accustem.com

Accustem Sciences Inc is a life sciences company dedicated to optimizing outcomes for all patients with cancer across the globe. The company takes a holistic view of its role in oncology to empower patients and care team with critical answers and tools and drive innovation in healthcare.